scispace - formally typeset
K

Kim Pettersson

Researcher at University of Turku

Publications -  260
Citations -  11749

Kim Pettersson is an academic researcher from University of Turku. The author has contributed to research in topics: Prostate cancer & Immunoassay. The author has an hindex of 60, co-authored 256 publications receiving 11104 citations. Previous affiliations of Kim Pettersson include Lund University & International Centre for Genetic Engineering and Biotechnology.

Papers
More filters
Journal ArticleDOI

Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.

TL;DR: To characterize the PSA immunoreactivity in serum, monoclonal antibodies produced against PSA and a polyclonal rabbit IgG against alpha 1-antichymotrypsin were used in the design of three noncompetitive PSA assays and an immunoreactive 25- to 40-kDa compound was the minor fraction.
Journal ArticleDOI

Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex

TL;DR: It is demonstrated that the main part of cTnI in serum collected from acute myocardial infarction patients is presented in the complex from CTnC, which results in a significant decrease of the interaction of mAbs with TnI.
Journal ArticleDOI

Biochemical markers of bone metabolism and prediction of fracture in elderly women.

TL;DR: In elderly women, TRACP5b and urinary fragments of osteocalcin are promising new markers for prediction of fracture, in particular, vertebral fracture.
Journal ArticleDOI

Degradation of cardiac troponin I: implication for reliable immunodetection

TL;DR: Analysis of the proteolytic degradation of cardiac troponin I in human necrotic tissue and in serum concludes that antibodies selected for cTnI sandwich immunoassays should preferentially recognize epitopes located in the region resistant to proteolysis.
Journal ArticleDOI

A supersensitive immunofluorometric assay for rat luteinizing hormone

TL;DR: An immunofluorometric assay (IFMA) for rat (r) LH, which is based on two monoclonal antibodies, one to bovine and the other to human LH, is developed, which means that only IFMA is able to provide meaningful measurements of suppressed levels of serum LH.